News and Trends 27 Apr 2023
Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’
Arrowhead Pharmaceuticals Inc. has announced interim results from an ongoing phase 1/2 clinical study of ARO-RAGE, an investigational RNA interference…